aspirin has been researched along with Airway Hyper-Responsiveness in 56 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This review is set to revisit the pathogenesis of aspirin-exacerbated respiratory disease (AERD), the diagnostic method used, and finally the real impact of aspirin desensitization on chronic sinusitis with nasal polyposis (CRSwNP) in aspirin intolerant patients." | 8.87 | Role of aspirin desensitization in the management of chronic rhinosinusitis. ( Rizk, H, 2011) |
| "Aspirin-exacerbated respiratory disease (AERD) is a chronic inflammatory disease characterized by chronic rhinosinusitis, nasal polyposis, asthma, and airway reactivity to aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs)." | 8.84 | The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis. ( Williams, AN; Woessner, KM, 2008) |
| " Aspirin-exacerbated respiratory disease (AERD) is defined as asthma, chronic rhinosinusitis with nasal polyposis, and hypersensitivity to cyclooxygenase-1 inhibitors." | 7.85 | Immunoglobulin G4 sinusitis in association with aspirin-exacerbated respiratory disease. ( Johal, K; Peters, A; Welch, K, 2017) |
| "Without prior exposure to aspirin or NSAIDs, the chance of a positive OAC was 5 in 12 (42%) but was 198 in 231 (86%) for those with a history of aspirin- and NSAID-associated asthma attacks." | 7.74 | Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. ( Dursun, AB; Karasoy, D; Simon, RA; Stevenson, DD; Woessner, KA, 2008) |
| "This study confirms the importance of eosinophil infiltration in the pathogenesis of severe or recurrent nasal polyps based on allergy and aspirin intolerance." | 7.70 | [Significance of eosinophilic granulocytes in relation to allergy and aspirin intolerance in patients with sinusitis polyposa]. ( Bittinger, F; Gosepath, J; Kaldenbach, T; Klimek, L; Mann, WJ; Schäfer, D, 1999) |
| "The high prevalence of aspirin intolerance in asthmatics and patients with nasal polyps as well as reports of familial clustering suggest a genetic disposition of this disease." | 7.70 | [Family study of patients with aspirin intolerance and rhinosinusitis]. ( Langenbeck, U; May, A; Wagner, D; Weber, A, 2000) |
| "Aspirin-exacerbated respiratory disease (AERD) is characterized by progressive sinusitis, nasal polyposis, and asthma that begins and continues in the absence of exposure to aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs)." | 5.11 | Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease. ( Simon, RA; Stevenson, DD; Woessner, KM, 2004) |
| "This review is set to revisit the pathogenesis of aspirin-exacerbated respiratory disease (AERD), the diagnostic method used, and finally the real impact of aspirin desensitization on chronic sinusitis with nasal polyposis (CRSwNP) in aspirin intolerant patients." | 4.87 | Role of aspirin desensitization in the management of chronic rhinosinusitis. ( Rizk, H, 2011) |
| "Aspirin-exacerbated respiratory disease (AERD) is a chronic inflammatory disease characterized by chronic rhinosinusitis, nasal polyposis, asthma, and airway reactivity to aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs)." | 4.84 | The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis. ( Williams, AN; Woessner, KM, 2008) |
| "Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinosinusitis, nasal polyposis, asthma and precipitation of asthma, and rhinitis attacks after ingestion of aspirin (ASA) and most other nonsteroidal antiinflammatory drugs (NSAIDs)." | 4.82 | Natural history and clinical features of aspirin-exacerbated respiratory disease. ( Fahrenholz, JM, 2003) |
| "Aspirin-exacerbated respiratory disease (AERD) is an adult-onset condition that manifests as asthma, rhinosinusitis/nasal polyps, and sensitivity to aspirin and other cyclooxygenase-1 (COX-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs)." | 4.82 | Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs. ( Simon, RA, 2004) |
| "Relevant articles in the medical literature were derived from searching the MEDLINE database with key terms aspirin-sensitive asthma, cyclo-oxygenase enzymes 1 and 2." | 4.81 | Sensitivity to nonsteroidal anti-inflammatory drugs. ( Namazy, JA; Simon, RA, 2002) |
| " Aspirin-exacerbated respiratory disease (AERD) is defined as asthma, chronic rhinosinusitis with nasal polyposis, and hypersensitivity to cyclooxygenase-1 inhibitors." | 3.85 | Immunoglobulin G4 sinusitis in association with aspirin-exacerbated respiratory disease. ( Johal, K; Peters, A; Welch, K, 2017) |
| "Multiple NSAID-induced urticaria/angioedema (MNSAID-UA) is an entity well differentiated from aspirin-exacerbated respiratory disease (AERD), although no detailed phenotype analysis has yet been performed." | 3.79 | Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs. ( Ayuso, P; Blanca, M; Blanca-López, N; Campo, P; Canto, G; Cornejo-García, JA; Doña, I; Guéant, JL; Plaza, MC; Salas, M; Sanak, M; Torres, MJ, 2013) |
| "Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome associated with chronic inflammation in the airways coincident with chronic rhinitis, sinusitis, recurrent polyposis and asthma." | 3.78 | Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease. ( Jin, HJ; Kim, SH; Park, HS; Song, YS; Yang, EM, 2012) |
| "Without prior exposure to aspirin or NSAIDs, the chance of a positive OAC was 5 in 12 (42%) but was 198 in 231 (86%) for those with a history of aspirin- and NSAID-associated asthma attacks." | 3.74 | Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. ( Dursun, AB; Karasoy, D; Simon, RA; Stevenson, DD; Woessner, KA, 2008) |
| " Often it is associated with non allergic rhinitis with eosinophilia syndrome (NARES), nasal polyposis and intolerance to Aspirin and NSAID's." | 3.74 | [Nonallergic diseases of the upper and lower airways]. ( Menz, G; Rothe, T, 2008) |
| "This study confirms the importance of eosinophil infiltration in the pathogenesis of severe or recurrent nasal polyps based on allergy and aspirin intolerance." | 3.70 | [Significance of eosinophilic granulocytes in relation to allergy and aspirin intolerance in patients with sinusitis polyposa]. ( Bittinger, F; Gosepath, J; Kaldenbach, T; Klimek, L; Mann, WJ; Schäfer, D, 1999) |
| "The high prevalence of aspirin intolerance in asthmatics and patients with nasal polyps as well as reports of familial clustering suggest a genetic disposition of this disease." | 3.70 | [Family study of patients with aspirin intolerance and rhinosinusitis]. ( Langenbeck, U; May, A; Wagner, D; Weber, A, 2000) |
| "The following beliefs about aspirin sensitivity are widely held: (1) it usually is accompanied by nasal polyps." | 3.65 | Aspirin allergy: a clinical study. ( Speer, F, 1975) |
| "Aspirin-like drugs inhibit the biosynthesis of prostaglandins in all tissues and species so far studied." | 2.35 | The mode of action of aspirin and similar compounds. ( Vane, JR, 1976) |
| "Misoprostol (200 μg) was administered at 30 minutes, 90 minutes, and 4 hours after the first dose of nasal ketorolac." | 1.46 | Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization. ( Simon, RA; Walters, KM; White, AA; Wineinger, NE; Woessner, KM, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (26.79) | 18.7374 |
| 1990's | 8 (14.29) | 18.2507 |
| 2000's | 23 (41.07) | 29.6817 |
| 2010's | 10 (17.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, KA | 1 |
| Modena, BD | 1 |
| Wineinger, NE | 2 |
| Woessner, KM | 5 |
| Simon, RA | 8 |
| White, AA | 3 |
| Walters, KM | 1 |
| Johal, K | 1 |
| Welch, K | 1 |
| Peters, A | 1 |
| Fruth, K | 1 |
| Pogorzelski, B | 1 |
| Schmidtmann, I | 1 |
| Springer, J | 1 |
| Fennan, N | 1 |
| Fraessdorf, N | 1 |
| Boessert, A | 1 |
| Schaefer, D | 1 |
| Gosepath, J | 2 |
| Mann, WJ | 2 |
| Campo, P | 1 |
| Ayuso, P | 1 |
| Salas, M | 1 |
| Plaza, MC | 1 |
| Cornejo-García, JA | 1 |
| Doña, I | 1 |
| Torres, MJ | 1 |
| Blanca-López, N | 1 |
| Canto, G | 1 |
| Guéant, JL | 1 |
| Sanak, M | 1 |
| Blanca, M | 1 |
| Baudrand, H | 1 |
| Zaouche, S | 1 |
| Dubost, R | 1 |
| Carsin, A | 1 |
| Chatte, G | 1 |
| Freymond, N | 1 |
| Piperno, D | 1 |
| Dubreuil, C | 1 |
| Froehlich, P | 1 |
| Pacheco, Y | 1 |
| Devouassoux, G | 1 |
| Teran, LM | 1 |
| Ramirez-Jimenez, F | 1 |
| Soid-Raggi, G | 1 |
| Velazquez, JR | 1 |
| Dursun, AB | 1 |
| Woessner, KA | 1 |
| Karasoy, D | 1 |
| Stevenson, DD | 5 |
| Rothe, T | 1 |
| Menz, G | 1 |
| Williams, AN | 1 |
| Das, S | 1 |
| Maeso, PA | 1 |
| Becker, AM | 1 |
| Prosser, JD | 1 |
| Adam, BL | 1 |
| Kountakis, SE | 1 |
| Taniguchi, M | 1 |
| Okano, M | 1 |
| Rizk, H | 1 |
| Song, YS | 1 |
| Yang, EM | 1 |
| Kim, SH | 1 |
| Jin, HJ | 1 |
| Park, HS | 1 |
| Namazy, JA | 1 |
| Fahrenholz, JM | 1 |
| Zuraw, BL | 1 |
| VIGUIE, R | 1 |
| GARDIES, AL | 1 |
| Solensky, R | 1 |
| Ramanuja, S | 1 |
| Breall, JA | 1 |
| Kalaria, VG | 1 |
| Shah, A | 1 |
| Panjabi, C | 1 |
| Semik, A | 1 |
| Barczyk, A | 1 |
| Pierzchała, W | 1 |
| Smith, WB | 1 |
| Wormald, PJ | 1 |
| Cohn, JR | 1 |
| Farooque, S | 1 |
| Lee, TH | 1 |
| Buisseret, PD | 1 |
| VanArsdel, PP | 1 |
| McFadden, ER | 1 |
| Busse, WW | 1 |
| Hassoun, S | 1 |
| Bonneau, JC | 1 |
| Drouet, M | 1 |
| Sabbah, A | 1 |
| Sainte-Laudy, J | 2 |
| Vallon, C | 2 |
| Guérin, JC | 2 |
| Blanco, C | 1 |
| Quiralte, J | 1 |
| Castillo, R | 1 |
| Delgado, J | 1 |
| Arteaga, C | 1 |
| Barber, D | 1 |
| Carrillo, T | 1 |
| Matsuse, H | 1 |
| Shimoda, T | 1 |
| Matsuo, N | 1 |
| Fukushima, C | 1 |
| Takao, A | 1 |
| Sakai, H | 1 |
| Asai, S | 1 |
| Kohno, S | 1 |
| Kaldenbach, T | 1 |
| Schäfer, D | 1 |
| Bittinger, F | 1 |
| Klimek, L | 1 |
| May, A | 1 |
| Wagner, D | 1 |
| Langenbeck, U | 1 |
| Weber, A | 1 |
| Udovicki, J | 1 |
| Milakov, J | 1 |
| Damnjanović-Cokić, J | 1 |
| Poljacki, M | 1 |
| Vane, JR | 1 |
| Speer, F | 1 |
| Vincent, D | 1 |
| Lefort, J | 1 |
| Bureau, M | 1 |
| Dry, J | 1 |
| Vargaftig, BB | 1 |
| Manning, ME | 1 |
| Jankowski, R | 1 |
| Béné, MC | 1 |
| Moneret-Vautrin, AD | 1 |
| Haas, F | 1 |
| Faure, G | 1 |
| Simon, C | 1 |
| Wayoff, M | 1 |
| Cooper, JA | 1 |
| Matthay, RA | 1 |
| Fisherman, EW | 1 |
| Cohen, GN | 1 |
| Fein, BT | 1 |
| Caplin, I | 1 |
| Haynes, JT | 1 |
| Spahn, J | 1 |
| Miller, FF | 1 |
| Girard, JP | 1 |
| Hildebrandt, F | 1 |
| Favre, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Dupilumab as add-on Therapy for Aspirin-exacerbated Respiratory Disease (AERD)[NCT03595488] | Phase 2 | 11 participants (Actual) | Interventional | 2018-09-05 | Completed | ||
| Improving Patient Care Via Proteomics Based, Microbe-Specific Detection of Chronic Rhinosinusitis[NCT00962689] | 38 participants (Actual) | Observational | 2009-08-31 | Completed | |||
| Double Blind Study to Determine Effect of Omalizumab Treatment in Patients With the Co-Morbid Conditions of Aspirin Exacerbated Respiratory Disease(AERD) and Allergic Asthma and Rhinitis.[NCT00286416] | 60 participants | Interventional | 2006-01-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for aspirin and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis.
Topics: Administration, Oral; Aspirin; Chronic Disease; Desensitization, Immunologic; Humans; Lysine; Nasal | 2008 |
Role of aspirin desensitization in the management of chronic rhinosinusitis.
Topics: Aspirin; Chronic Disease; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Nasal Polyps; | 2011 |
Sensitivity to nonsteroidal anti-inflammatory drugs.
Topics: Acetaminophen; Adult; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bleedin | 2002 |
Natural history and clinical features of aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Provocation Tests; Cross Reactio | 2003 |
Crossreacting drugs and chemicals.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross Reactions; Cyclooxygenase 1; Cyclooxygenase | 2003 |
Aspirin desensitization in patients with AERD.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Desensitization, Immunologic; Dose-Response Relati | 2003 |
Prevention and treatment of reactions to NSAIDs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross Reactions; Cyclooxygenase Inhibitors; Desens | 2003 |
Pathogenesis of aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase | 2003 |
Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Cyclooxygenase Inhibitors; Desensit | 2004 |
Treatment of patients with respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross Reactions; Cyclooxygenase Inhibitors; Diseas | 2004 |
Drug allergy: desensitization and treatment of reactions to antibiotics and aspirin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dese | 2004 |
Approach to "aspirin allergy" in cardiovascular patients.
Topics: Anaphylaxis; Aspirin; Coronary Artery Disease; Drug Hypersensitivity; Humans; Platelet Aggregation I | 2004 |
[Provocation tests in the diagnosis of acetylsalicylic acid intolerance].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Provocation Tests; Drug Hypersen | 2005 |
The mode of action of aspirin and similar compounds.
Topics: Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Bronchi; Dermatitis, Atopic; Drug Hypersensiti | 1976 |
Drug-induced pulmonary disease.
Topics: Anti-Arrhythmia Agents; Anticonvulsants; Antineoplastic Agents; Aspirin; Gold; Humans; Hydrochloroth | 1987 |
2 trials available for aspirin and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease.
Topics: Adult; Aspirin; Desensitization, Immunologic; Drug Hypersensitivity; Female; Follow-Up Studies; Huma | 2013 |
Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Cross Reactions; Cyclooxygenase Inhibitors | 2004 |
39 other studies available for aspirin and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Use of a composite symptom score during challenge in patients with suspected aspirin-exacerbated respiratory disease.
Topics: Adult; Aged; Aspirin; Drug Hypersensitivity; Female; Humans; Immunization; Immunoglobulin E; Male; M | 2017 |
Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization.
Topics: Adolescent; Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Desensit | 2017 |
Immunoglobulin G4 sinusitis in association with aspirin-exacerbated respiratory disease.
Topics: Aspirin; Asthma, Aspirin-Induced; Humans; Immunoglobulin G; Male; Middle Aged; Nasal Polyps; Respira | 2017 |
An update on the epidemiology of aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; Humans; Nasal Polyps; Pre | 2017 |
Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Stero | 2013 |
[Aspirin hypersensitivity: characteristics and diagnostic approach].
Topics: Adult; Aged; Anti-Asthmatic Agents; Aspirin; Asthma; Blood Cell Count; Blood Platelets; Comorbidity; | 2015 |
Interleukin 16 and CCL17/thymus and activation-regulated chemokine in patients with aspirin-exacerbated respiratory disease.
Topics: Adult; Aspirin; Biomarkers; Chemokine CCL17; Drug Hypersensitivity; Eosinophils; Female; Humans; Imm | 2017 |
Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis.
Topics: Administration, Oral; Adult; Age Factors; Aspirin; Asthma; Drug Hypersensitivity; Female; Forced Exp | 2008 |
[Nonallergic diseases of the upper and lower airways].
Topics: Aspirin; Asthma; Bronchitis; Diagnosis, Differential; Drug Hypersensitivity; Eosinophilia; Humans; I | 2008 |
Proteomics blood testing to distinguish chronic rhinosinusitis subtypes.
Topics: Aspirin; Asthma; Biomarkers; Chronic Disease; Diagnosis, Differential; Drug Hypersensitivity; Fungi; | 2008 |
[Measurement of airway hyperresponsiveness and aspirin sensitivity].
Topics: Aspirin; Humans; Respiratory Hypersensitivity | 2009 |
[Aspirin intolerance--from the viewpoint of otorhinolaryngology].
Topics: Aspirin; Humans; Respiratory Hypersensitivity | 2009 |
Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease.
Topics: Adult; Arachidonate 15-Lipoxygenase; Asian People; Aspirin; Asthma; Asthma, Aspirin-Induced; Base Se | 2012 |
[IS ASPIRIN A DANGEROUS DRUG?].
Topics: Anemia; Anemia, Hypochromic; Angioedema; Anticoagulants; Aspirin; Asthma; Blood Coagulation Disorder | 1963 |
Asthma, hypersensitivity, and coitus.
Topics: Aspirin; Asthma; Coitus; Follow-Up Studies; Humans; Male; Middle Aged; Respiratory Hypersensitivity; | 2004 |
Allergy and sinus disease.
Topics: Anti-Allergic Agents; Aspirin; Drug Hypersensitivity; Humans; Nasal Polyps; Respiratory Hypersensiti | 2006 |
Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
Topics: Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Desensitization, Immunologic; Drug Hy | 2007 |
Aspirin sensitivity and eicosanoids.
Topics: Aspirin; Cyclooxygenase Inhibitors; Drug Hypersensitivity; Eicosanoids; Humans; Respiratory Hypersen | 2008 |
Allergy.
Topics: Animals; Antibody Formation; Arachidonic Acids; Aspirin; Autacoids; B-Lymphocytes; Cromolyn Sodium; | 1982 |
Aspirin idiosyncracy and tolerance.
Topics: Adult; Anti-Inflammatory Agents; Aspirin; Desensitization, Immunologic; Drug Tolerance; Female; Huma | 1984 |
Pathogenesis of asthma.
Topics: Adult; Air Pollution; Allergens; Animals; Aspirin; Asthma; Asthma, Exercise-Induced; Bronchi; Bronch | 1984 |
Clinical aspects of bronchial asthma.
Topics: Aspirin; Asthma; Carbon Dioxide; Environmental Pollutants; Humans; Medical History Taking; Oxygen; P | 1980 |
[Survey of pathologies caused by sulfites in allergology].
Topics: Adolescent; Adult; Aspirin; Child; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Female; F | 1994 |
[Importance of the leukotriene C4 liberation test for the diagnosis of drug allergy (preliminary results)].
Topics: Adult; Allergens; Ampicillin; Animals; Aspirin; Basophil Degranulation Test; Basophils; Cats; Drug E | 1996 |
Anaphylaxis after ingestion of wheat flour contaminated with mites.
Topics: Adolescent; Adult; Allergens; Anaphylaxis; Animals; Antibodies, Monoclonal; Antigens, Dermatophagoid | 1997 |
Aspirin-induced asthma as a risk factor for asthma mortality.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Hyperreactivity; Br | 1997 |
[Significance of eosinophilic granulocytes in relation to allergy and aspirin intolerance in patients with sinusitis polyposa].
Topics: Adult; Aged; Aspirin; Drug Hypersensitivity; Eosinophilia; Eosinophils; Female; Humans; Male; Middle | 1999 |
[Family study of patients with aspirin intolerance and rhinosinusitis].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Provocation T | 2000 |
[Nasal polyposis and allergy to aspirin].
Topics: Adolescent; Adult; Aged; Aspirin; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Nasal Po | 1979 |
Aspirin allergy: a clinical study.
Topics: Adolescent; Adult; Angioedema; Aspirin; Asthma; Child; Child, Preschool; Drug Hypersensitivity; Fema | 1975 |
[A familial case of metabisulfite intolerance. Clinical and pharmacological study].
Topics: Adult; Alcoholic Beverages; Aspirin; Basophil Degranulation Test; Drug Hypersensitivity; Female; Foo | 1992 |
Dissociation between LPS-induced bronchial hyperreactivity and airway edema in the guinea-pig.
Topics: Animals; Aspirin; Azepines; Bronchial Diseases; Bronchoalveolar Lavage Fluid; Escherichia coli; Guin | 1991 |
Aspirin sensitivity. A distressing reaction that is now often treatable.
Topics: Aspirin; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Respiratory Hypersensitivity | 1991 |
Immunohistological characteristics of nasal polyps. A comparison with healthy mucosa and chronic sinusitis.
Topics: Adolescent; Adult; Aged; Antigen-Antibody Complex; Aspirin; Asthma; Complement System Proteins; Drug | 1989 |
Cholinergic and adrenergic stimulation correlated with aspirin intolerance (hypersensitivity).
Topics: Aspirin; Atropine; Blood Coagulation; Blood Coagulation Tests; Drug Hypersensitivity; Ergonovine; Hu | 1974 |
Aspirin shock associated with asthma and nasal polyps.
Topics: Adolescent; Adult; Aspirin; Asthma; Bronchial Spasm; Child; Child, Preschool; Drug Hypersensitivity; | 1971 |
Are nasal polyps an allergic phenomenon?
Topics: Aspirin; Asthma; Cystic Fibrosis; Dermatitis, Atopic; Drug Hypersensitivity; Female; Humans; Hyperse | 1971 |
History of drug sensitivity in atopic persons.
Topics: Aspirin; Asthma; Drug Hypersensitivity; Health Surveys; Penicillins; Respiratory Hypersensitivity; S | 1967 |
Hypersensitivity to aspirin: clinical and immunological studies.
Topics: Aged; Angioedema; Aspirin; Drug Hypersensitivity; Hemagglutination Tests; Humans; Male; Respiratory | 1969 |